Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

TLPH vs PRGO vs MCK vs CAH vs CVS

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
TLPH
Talphera, Inc.

Drug Manufacturers - Specialty & Generic

HealthcareNASDAQ • US
Market Cap$43M
5Y Perf.-96.8%
PRGO
Perrigo Company plc

Drug Manufacturers - Specialty & Generic

HealthcareNYSE • IE
Market Cap$1.61B
5Y Perf.-78.6%
MCK
McKesson Corporation

Medical - Distribution

HealthcareNYSE • US
Market Cap$92.15B
5Y Perf.+374.1%
CAH
Cardinal Health, Inc.

Medical - Distribution

HealthcareNYSE • US
Market Cap$43.59B
5Y Perf.+238.7%
CVS
CVS Health Corporation

Medical - Healthcare Plans

HealthcareNYSE • US
Market Cap$111.40B
5Y Perf.+33.2%

TLPH vs PRGO vs MCK vs CAH vs CVS — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
TLPH logoTLPH
PRGO logoPRGO
MCK logoMCK
CAH logoCAH
CVS logoCVS
IndustryDrug Manufacturers - Specialty & GenericDrug Manufacturers - Specialty & GenericMedical - DistributionMedical - DistributionMedical - Healthcare Plans
Market Cap$43M$1.61B$92.15B$43.59B$111.40B
Revenue (TTM)$28K$4.18B$403.43B$250.55B$407.90B
Net Income (TTM)$-14M$-1.82B$4.76B$1.56B$2.93B
Gross Margin-40.8%34.2%3.6%3.7%13.9%
Operating Margin-481.6%-4.1%1.5%0.9%1.5%
Forward P/E5.6x19.3x17.9x12.2x
Total Debt$0.00$3.97B$7.39B$9.35B$93.59B
Cash & Equiv.$6M$532M$5.69B$3.87B$8.51B

TLPH vs PRGO vs MCK vs CAH vs CVSLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

TLPH
PRGO
MCK
CAH
CVS
StockMay 20May 26Return
Talphera, Inc. (TLPH)1003.2-96.8%
Perrigo Company plc (PRGO)10021.4-78.6%
McKesson Corporation (MCK)100474.1+374.1%
Cardinal Health, In… (CAH)100338.7+238.7%
CVS Health Corporat… (CVS)100133.2+33.2%

Price return only. Dividends and distributions are not included.

Quick Verdict: TLPH vs PRGO vs MCK vs CAH vs CVS

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: MCK leads in 3 of 7 categories (5-stock set), making it the strongest pick for growth and revenue expansion and profitability and margin quality. Perrigo Company plc is the stronger pick specifically for valuation and capital efficiency and dividend income and shareholder returns. TLPH and CAH also each lead in at least one category. As sector peers, any of these can serve as alternatives in the same allocation.
TLPH
Talphera, Inc.
The Momentum Pick

TLPH ranks third and is worth considering specifically for momentum.

  • +70.5% vs PRGO's -51.2%
Best for: momentum
PRGO
Perrigo Company plc
The Value Play

PRGO is the #2 pick in this set and the best alternative if value and dividends is your priority.

  • Lower P/E (5.6x vs 12.2x)
  • 9.8% yield, 10-year raise streak, vs CAH's 1.1%, (1 stock pays no dividend)
Best for: value and dividends
MCK
McKesson Corporation
The Growth Play

MCK carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth 16.2%, EPS growth 14.9%, 3Y rev CAGR 10.8%
  • 348.1% 10Y total return vs CAH's 160.8%
  • 16.2% revenue growth vs TLPH's -18.2%
  • 1.2% margin vs TLPH's -510.4%
Best for: growth exposure and long-term compounding
CAH
Cardinal Health, Inc.
The Income Pick

CAH is the clearest fit if your priority is income & stability and sleep-well-at-night.

  • Dividend streak 20 yrs, beta 0.03, yield 1.1%
  • Lower volatility, beta 0.03, current ratio 0.94x
  • Beta 0.03, yield 1.1%, current ratio 0.94x
  • Beta 0.03 vs PRGO's 1.18
Best for: income & stability and sleep-well-at-night
CVS
CVS Health Corporation
The Insurance Play

Among these 5 stocks, CVS doesn't own a clear edge in any measured category.

Best for: healthcare exposure
See the full category breakdown
CategoryWinnerWhy
GrowthMCK logoMCK16.2% revenue growth vs TLPH's -18.2%
ValuePRGO logoPRGOLower P/E (5.6x vs 12.2x)
Quality / MarginsMCK logoMCK1.2% margin vs TLPH's -510.4%
Stability / SafetyCAH logoCAHBeta 0.03 vs PRGO's 1.18
DividendsPRGO logoPRGO9.8% yield, 10-year raise streak, vs CAH's 1.1%, (1 stock pays no dividend)
Momentum (1Y)TLPH logoTLPH+70.5% vs PRGO's -51.2%
Efficiency (ROA)MCK logoMCK5.7% ROA vs TLPH's -62.2%, ROIC 5.4% vs -120.3%

TLPH vs PRGO vs MCK vs CAH vs CVS — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

TLPHTalphera, Inc.

Segment breakdown not available.

PRGOPerrigo Company plc
FY 2025
Consumer Self-Care Americas
60.8%$2.6B
Consumer Self-Care International
39.2%$1.7B
MCKMcKesson Corporation
FY 2025
U.S. Pharmaceutical Segment
91.3%$327.7B
International Segment
4.1%$14.7B
Medical-Surgical Solutions Segment
3.2%$11.4B
Prescription Technology Solutions
1.5%$5.2B
CAHCardinal Health, Inc.
FY 2025
Pharmaceutical Member
91.9%$204.6B
GMPD
5.7%$12.6B
Other Operating Segment
2.4%$5.4B
CVSCVS Health Corporation
FY 2025
Pharmacy Revenue
58.9%$229.0B
Premiums
34.6%$134.8B
Front Store Revenue
5.5%$21.5B
Product and Service, Other
1.0%$3.9B

TLPH vs PRGO vs MCK vs CAH vs CVS — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLPRGOLAGGINGCVS

Income & Cash Flow (Last 12 Months)

Evenly matched — PRGO and MCK each lead in 2 of 6 comparable metrics.

CVS is the larger business by revenue, generating $407.9B annually — 14568035.7x TLPH's $28,000. MCK is the more profitable business, keeping 1.2% of every revenue dollar as net income compared to TLPH's -510.4%. On growth, CAH holds the edge at +11.0% YoY revenue growth, suggesting stronger near-term business momentum.

MetricTLPH logoTLPHTalphera, Inc.PRGO logoPRGOPerrigo Company p…MCK logoMCKMcKesson Corporat…CAH logoCAHCardinal Health, …CVS logoCVSCVS Health Corpor…
RevenueTrailing 12 months$28,000$4.2B$403.4B$250.5B$407.9B
EBITDAEarnings before interest/tax-$11M$58M$6.8B$3.2B$10.5B
Net IncomeAfter-tax profit-$14M-$1.8B$4.8B$1.6B$2.9B
Free Cash FlowCash after capex-$11M$108M$6.0B$4.4B$7.4B
Gross MarginGross profit ÷ Revenue-40.8%+34.2%+3.6%+3.7%+13.9%
Operating MarginEBIT ÷ Revenue-481.6%-4.1%+1.5%+0.9%+1.5%
Net MarginNet income ÷ Revenue-510.4%-43.5%+1.2%+0.6%+0.7%
FCF MarginFCF ÷ Revenue-405.9%+2.6%+1.5%+1.8%+1.8%
Rev. Growth (YoY)Latest quarter vs prior year-7.2%+6.0%+11.0%+6.2%
EPS Growth (YoY)Latest quarter vs prior year+56.1%-56.4%+37.0%-19.5%+63.1%
Evenly matched — PRGO and MCK each lead in 2 of 6 comparable metrics.

Valuation Metrics

PRGO leads this category, winning 4 of 6 comparable metrics.

At 28.7x trailing earnings, CAH trades at a 54% valuation discount to CVS's 62.8x P/E. On an enterprise value basis, PRGO's 7.4x EV/EBITDA is more attractive than MCK's 18.7x.

MetricTLPH logoTLPHTalphera, Inc.PRGO logoPRGOPerrigo Company p…MCK logoMCKMcKesson Corporat…CAH logoCAHCardinal Health, …CVS logoCVSCVS Health Corpor…
Market CapShares × price$43M$1.6B$92.1B$43.6B$111.4B
Enterprise ValueMkt cap + debt − cash$37M$5.1B$93.8B$49.1B$196.5B
Trailing P/EPrice ÷ TTM EPS-2.58x-1.14x29.25x28.72x62.81x
Forward P/EPrice ÷ next-FY EPS est.5.56x19.28x17.94x12.19x
PEG RatioP/E ÷ EPS growth rate0.75x
EV / EBITDAEnterprise value multiple7.42x18.74x16.01x13.11x
Price / SalesMarket cap ÷ Revenue1547.32x0.38x0.26x0.20x0.28x
Price / BookPrice ÷ Book value/share2.19x0.55x1.47x
Price / FCFMarket cap ÷ FCF11.12x17.63x23.56x14.27x
PRGO leads this category, winning 4 of 6 comparable metrics.

Profitability & Efficiency

MCK leads this category, winning 5 of 9 comparable metrics.

MCK delivers a 3.0% return on equity — every $100 of shareholder capital generates $3 in annual profit, vs $-118 for TLPH. CVS carries lower financial leverage with a 1.24x debt-to-equity ratio, signaling a more conservative balance sheet compared to PRGO's 1.35x. On the Piotroski fundamental quality scale (0–9), MCK scores 6/9 vs PRGO's 4/9, reflecting solid financial health.

MetricTLPH logoTLPHTalphera, Inc.PRGO logoPRGOPerrigo Company p…MCK logoMCKMcKesson Corporat…CAH logoCAHCardinal Health, …CVS logoCVSCVS Health Corpor…
ROE (TTM)Return on equity-118.0%-50.7%+3.0%+3.9%
ROA (TTM)Return on assets-62.2%-19.8%+5.7%+2.8%+1.1%
ROICReturn on invested capital-120.3%+3.7%+5.4%+33.8%+5.0%
ROCEReturn on capital employed-65.0%+4.3%+30.5%+19.2%+6.1%
Piotroski ScoreFundamental quality 0–944665
Debt / EquityFinancial leverage1.35x1.24x
Net DebtTotal debt minus cash-$6M$3.4B$1.7B$5.5B$85.1B
Cash & Equiv.Liquid assets$6M$532M$5.7B$3.9B$8.5B
Total DebtShort + long-term debt$0$4.0B$7.4B$9.3B$93.6B
Interest CoverageEBIT ÷ Interest expense-7.20x33.79x6.38x2.11x
MCK leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

Evenly matched — MCK and CAH each lead in 2 of 6 comparable metrics.

A $10,000 investment in MCK five years ago would be worth $38,689 today (with dividends reinvested), compared to $385 for TLPH. Over the past 12 months, TLPH leads with a +70.5% total return vs PRGO's -51.2%. The 3-year compound annual growth rate (CAGR) favors CAH at 31.5% vs PRGO's -25.2% — a key indicator of consistent wealth creation.

MetricTLPH logoTLPHTalphera, Inc.PRGO logoPRGOPerrigo Company p…MCK logoMCKMcKesson Corporat…CAH logoCAHCardinal Health, …CVS logoCVSCVS Health Corpor…
YTD ReturnYear-to-date-24.3%-13.5%-8.5%-9.5%+10.6%
1-Year ReturnPast 12 months+70.5%-51.2%+4.6%+22.0%+34.7%
3-Year ReturnCumulative with dividends+18.7%-58.1%+106.4%+127.3%+36.6%
5-Year ReturnCumulative with dividends-96.1%-60.1%+286.9%+235.7%+17.0%
10-Year ReturnCumulative with dividends-98.6%-77.7%+348.1%+160.8%+3.5%
CAGR (3Y)Annualised 3-year return+5.9%-25.2%+27.3%+31.5%+11.0%
Evenly matched — MCK and CAH each lead in 2 of 6 comparable metrics.

Risk & Volatility

Evenly matched — CAH and CVS each lead in 1 of 2 comparable metrics.

CAH is the less volatile stock with a 0.03 beta — it tends to amplify market swings less than PRGO's 1.18 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CVS currently trades 98.5% from its 52-week high vs PRGO's 41.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricTLPH logoTLPHTalphera, Inc.PRGO logoPRGOPerrigo Company p…MCK logoMCKMcKesson Corporat…CAH logoCAHCardinal Health, …CVS logoCVSCVS Health Corpor…
Beta (5Y)Sensitivity to S&P 5001.10x1.18x0.04x0.03x0.05x
52-Week HighHighest price in past year$1.57$28.44$999.00$233.60$88.63
52-Week LowLowest price in past year$0.38$9.23$637.00$137.75$58.35
% of 52W HighCurrent price vs 52-week peak+55.9%+41.2%+75.3%+79.3%+98.5%
RSI (14)Momentum oscillator 0–10055.760.916.233.269.3
Avg Volume (50D)Average daily shares traded164K3.4M757K1.7M7.4M
Evenly matched — CAH and CVS each lead in 1 of 2 comparable metrics.

Analyst Outlook

Evenly matched — PRGO and CAH each lead in 1 of 2 comparable metrics.

Analyst consensus: PRGO as "Hold", MCK as "Buy", CAH as "Buy", CVS as "Buy". Consensus price targets imply 70.6% upside for PRGO (target: $20) vs 9.0% for CVS (target: $95). For income investors, PRGO offers the higher dividend yield at 9.81% vs MCK's 0.36%.

MetricTLPH logoTLPHTalphera, Inc.PRGO logoPRGOPerrigo Company p…MCK logoMCKMcKesson Corporat…CAH logoCAHCardinal Health, …CVS logoCVSCVS Health Corpor…
Analyst RatingConsensus buy/hold/sellHoldBuyBuyBuy
Price TargetConsensus 12-month target$20.00$1006.50$249.67$95.20
# AnalystsCovering analysts36313341
Dividend YieldAnnual dividend ÷ price+9.8%+0.4%+1.1%+3.1%
Dividend StreakConsecutive years of raises1017200
Dividend / ShareAnnual DPS$1.15$2.69$2.04$2.67
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%+3.4%+1.8%0.0%
Evenly matched — PRGO and CAH each lead in 1 of 2 comparable metrics.
Key Takeaway

PRGO leads in 1 of 6 categories (Valuation Metrics). MCK leads in 1 (Profitability & Efficiency). 4 tied.

Best OverallPerrigo Company plc (PRGO)Leads 1 of 6 categories
Loading custom metrics...

TLPH vs PRGO vs MCK vs CAH vs CVS: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is TLPH or PRGO or MCK or CAH or CVS a better buy right now?

For growth investors, McKesson Corporation (MCK) is the stronger pick with 16.

2% revenue growth year-over-year, versus -2. 8% for Perrigo Company plc (PRGO). Cardinal Health, Inc. (CAH) offers the better valuation at 28. 7x trailing P/E (17. 9x forward), making it the more compelling value choice. Analysts rate McKesson Corporation (MCK) a "Buy" — based on 31 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — TLPH or PRGO or MCK or CAH or CVS?

On trailing P/E, Cardinal Health, Inc.

(CAH) is the cheapest at 28. 7x versus CVS Health Corporation at 62. 8x. On forward P/E, Perrigo Company plc is actually cheaper at 5. 6x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — TLPH or PRGO or MCK or CAH or CVS?

Over the past 5 years, McKesson Corporation (MCK) delivered a total return of +286.

9%, compared to -96. 1% for Talphera, Inc. (TLPH). Over 10 years, the gap is even starker: MCK returned +348. 1% versus TLPH's -98. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — TLPH or PRGO or MCK or CAH or CVS?

By beta (market sensitivity over 5 years), Cardinal Health, Inc.

(CAH) is the lower-risk stock at 0. 03β versus Perrigo Company plc's 1. 18β — meaning PRGO is approximately 3385% more volatile than CAH relative to the S&P 500. On balance sheet safety, CVS Health Corporation (CVS) carries a lower debt/equity ratio of 124% versus 135% for Perrigo Company plc — giving it more financial flexibility in a downturn.

05

Which is growing faster — TLPH or PRGO or MCK or CAH or CVS?

By revenue growth (latest reported year), McKesson Corporation (MCK) is pulling ahead at 16.

2% versus -2. 8% for Perrigo Company plc (PRGO). On earnings-per-share growth, the picture is similar: Cardinal Health, Inc. grew EPS 87. 0% year-over-year, compared to -723. 2% for Perrigo Company plc. Over a 3-year CAGR, MCK leads at 10. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — TLPH or PRGO or MCK or CAH or CVS?

McKesson Corporation (MCK) is the more profitable company, earning 0.

9% net margin versus -510. 4% for Talphera, Inc. — meaning it keeps 0. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PRGO leads at 8. 1% versus -481. 6% for TLPH. At the gross margin level — before operating expenses — PRGO leads at 35. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is TLPH or PRGO or MCK or CAH or CVS more undervalued right now?

On forward earnings alone, Perrigo Company plc (PRGO) trades at 5.

6x forward P/E versus 19. 3x for McKesson Corporation — 13. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PRGO: 70. 6% to $20. 00.

08

Which pays a better dividend — TLPH or PRGO or MCK or CAH or CVS?

In this comparison, PRGO (9.

8% yield), CVS (3. 1% yield), CAH (1. 1% yield), MCK (0. 4% yield) pay a dividend. TLPH does not pay a meaningful dividend and should not be held primarily for income.

09

Is TLPH or PRGO or MCK or CAH or CVS better for a retirement portfolio?

For long-horizon retirement investors, Cardinal Health, Inc.

(CAH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 03), 1. 1% yield, +160. 8% 10Y return). Both have compounded well over 10 years (CAH: +160. 8%, TLPH: -98. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between TLPH and PRGO and MCK and CAH and CVS?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: TLPH is a small-cap quality compounder stock; PRGO is a small-cap income-oriented stock; MCK is a mid-cap high-growth stock; CAH is a mid-cap quality compounder stock; CVS is a mid-cap income-oriented stock. PRGO, CAH, CVS pay a dividend while TLPH, MCK do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

TLPH

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Stocks Like

PRGO

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 20%
  • Dividend Yield > 3.9%
Run This Screen
Stocks Like

MCK

Stable Dividend Mega-Cap

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Dividend Yield > 0.5%
Run This Screen
Stocks Like

CAH

Stable Dividend Mega-Cap

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Dividend Yield > 0.5%
Run This Screen
Stocks Like

CVS

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Dividend Yield > 1.2%
Run This Screen

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.